Zyvox / Tygacil & Thrombin-JMI combined salesforce

Discussion in 'Pfizer' started by Anonymous, Jun 5, 2013 at 8:51 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Ultimately we are here to serve the stockholders and raise the stock price. Giving the IS team Thrombin-JMI makes the most financial sense. We have roughly 100 Thrombin-JMI reps being compensated through company cars, insurance, base salary, bonuses, etc. at approximately $275,000 each total. Their managers and support personnel add another big chunk of change as well. We are at $27.5 million just for the sales force. Probably $12 million for management's total compensation including cars, insurance, pay, etc.
     

  2. Anonymous

    Anonymous Guest

    Wasn't part of the King buy-out a 3 year agreement to hold on to the Thrombin JMI sales force? When the 3 years are up, what happens? It seems that Pfizer's buying of King occurred 3 years ago this coming October/November.
     
  3. Anonymous

    Anonymous Guest

    Bullllllshit! Anytime you want to step into a spine surgery and go head-to-head with a surgeon
    while a patient is lying on a table cut open from his ass crack to the base of his neck, let me know, because we do that every day, and yeah, that makes us kind of special you suit and tie.
     
  4. Anonymous

    Anonymous Guest

    And what exactly are you going to tell the surgeon in surgery how to use gelfoam that they have been using for 50-60 years!! Not that impressed ith your supposedly talents
     
  5. Anonymous

    Anonymous Guest

    does it matter any more? neither of use has any sales numbers. we are still in an "operational excellence" framework so we below pay grade 25 are getting nickel and dimmed to pay for the ELT's bonus package.

    can't you see what is happening? in our society in general, the top 1% control 92% of US wealth. the middle class of the 50s - 90s is gone. we are like mexico now.

    same thing here.

    rise up Nubian princesses! rise up!
     
  6. Anonymous

    Anonymous Guest


    You make a very good point here. This is still an idea that our leadership should consider.
     
  7. Anonymous

    Anonymous Guest

    +1